Literature DB >> 4044993

Third generation cephalosporins--a panacea for intensive care patients?

F A Waldvogel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4044993     DOI： 10.1007/BF00272400

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

Review 1.  Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

2.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

3.  Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.

Authors:  M F Lampe; B J Allan; B H Minshew; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

4.  Moxalactam in nosocomial infections with Serratia marcescens.

Authors:  T Mall; F Follath; M Salfinger; R Ritz; H Reber
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

5.  A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.

Authors:  L Gutmann; R Williamson
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

6.  Enterococcal infections in patients treated with moxalactam.

Authors:  R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.